KFKavindya Fernando

Kavindya Fernando

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kavindya Fernando has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genotypic‐Phenotypic Correlations in Non‐ HbE β‐Thalassemia Intermedia: A Geographic Systematic Review

    by Kavindya Fernando, Shiromi Perera, Anuja Premawardhena

    Background: β‐thalassemia intermedia (β‐TI), now more commonly classified within the spectrum of non‐transfusion‐dependent thalassemia (NTDT), is a clinically heterogeneous disorder in which disease severity is determined not only by β‐globin mutations but also by co‐inherited genetic modifiers that vary across populations. These include α‐globin gene alterations, fetal haemoglobin (HbF)‐inducing polymorphisms, and other regulatory loci that influence globin chain balance. Methods: A systematic review was conducted in accordance with PRISMA 2020 guidelines. PubMed was searched from inception to May 2026, supplemented by citation tracking and manual screening. Studies reporting genotype–phenotype correlations in β‐TI were included. Data were synthesized qualitatively by geographic region. Results: Twenty‐one studies were included. The available evidence suggests Mediterranean populations are primarily influenced by mild β‐globin mutations. In Middle Eastern populations, HbF‐inducing polymorphisms, particularly the XmnI variant, played a prominent role, often mitigating severe genotypes. Among the included studies, Asian populations exhibited the greatest molecular heterogeneity, with α‐globin gene dosage alterations, including triplication, contributing substantially to disease expression. Conclusion: The available evidence suggests regional differences in the contribution of genetic modifiers to the β‐thalassemia intermedia phenotype. Recognition of these patterns may improve understanding of genotype–phenotype variability and may help inform future approaches to diagnosis, prognostication, and individualized therapeutic strategies.

  • Open Access

    Are Current Lipid Guidelines Adequate for South Asian Patients? A Narrative Review

    by Kavindya Fernando, Shamila De Silva

    South Asians, who account for nearly one quarter of the world’s population, experience a disproportionately high burden of atherosclerotic cardiovascular disease (ASCVD), often presenting 5–10 years earlier than European populations. This review evaluates whether contemporary lipid-management frameworks adequately address cardiovascular risk in South Asians. South Asians exhibit a distinct lipid phenotype characterised by elevated apolipoprotein B (ApoB), hypertriglyceridaemia, reduced HDL-cholesterol (HDL-C), increased small dense LDL (sdLDL) particles, and a high prevalence of elevated lipoprotein(a) (Lp(a)), features that are incompletely captured by conventional LDL-cholesterol (LDL-C)-based approaches. Existing cardiovascular risk tools show variable performance in South Asian populations, while contemporary guidelines differ substantially in risk assessment, LDL-cholesterol targets, incorporation of risk enhancers, and use of coronary artery calcium (CAC) scoring. Although recent guideline updates increasingly acknowledge South Asian ethnicity as a risk modifier, important gaps in calibration and implementation remain. Greater harmonisation of recommendations and validation of South Asian-specific risk assessment strategies are needed to improve cardiovascular prevention.

  • Open Access

    Factors Associated with Vitamin D Deficiency Among Patients Referred for Vitamin D Testing in a Sri Lankan Tertiary Care Hospital: A Retrospective Analysis

    by S. A. Ratnayake, D. N. Ratnatilleke, S. I. Rupasinghe, M. U. Sajana, N. R. Samarakkodi, K.M. Fernando, C. D. Mettananda

    Background: Vitamin D deficiency (VDD) remains a common global health concern, including in tropical countries with abundant sunlight exposure. However, limited evidence exists regarding factors associated with VDD in Sri Lankan clinical populations. This study aimed to identify demographic, behavioural and clinical factors associated with VDD among patients referred for serum vitamin D testing at a tertiary care hospital in Sri Lanka.Methods: This retrospective hospital-based study included 427 patients who underwent serum 25-hydroxyvitamin D [25(OH)D] testing at the Colombo North Teaching Hospital, Ragama, between March 2021 and March 2022. VDD was defined as serum 25(OH)D levels <30 ng/mL according to Endocrine Society guidelines. Sociodemographic, lifestyle and clinical data were collected using interviewer-administered questionnaires. Multivariable binary logistic regression was performed to identify factors independently associated with VDD.Results: Among patients referred for vitamin D testing, 353 (82.7%) had VDD. In multivariable logistic regression analysis, increasing age was independently associated with lower odds of VDD (AOR 0.969 per year increase, 95% CI 0.948-0.990; p = 0.004). Female sex (AOR 2.210; 95% CI 1.167–4.186; p=0.015), and sun-protective behaviours (AOR 2.378; 95% CI 1.315–4.302; p=0.004) were independently associated with higher odds of VDD. Ethnicity, smoking status, medication use, chronic disease status and vitamin D–rich diet was not significantly associated with VDD.Conclusions: In this hospital-based cohort referred for vitamin D testing, younger age, female sex and sun protective behaviours were independently associated with VDD. These findings highlight the importance of behavioural and demographic factors influencing vitamin D status in clinically suspected populations in tropical settings.

  • Open Access

    Diagnostic accuracy of glycated albumin and fructosamine for detecting diabetes and prediabetes in adults: a systematic review and meta-analysis protocol

    by Kavindya Fernando, Dulani Kottahachchi, Lochana Pasan, Chamodi Rathnaweera, Bktp Dayanath, Shiromi Perera, Anuja Premawardhena

    Early and accurate diagnosis of diabetes is essential to prevent long-term complications. While the oral glucose tolerance test (OGTT) is the reference sta


  • Open Access

    Longitudinal Predictors of Leg Ulceration in Thalassaemia Syndromes: Evidence for a Critical Haemoglobin Threshold in E-β Thalassaemia

    by Shiromi Perera, Dileepa Ediriweera, Janidu Karunarthna, Senani Williams, Kavindya Fernando, Anuja Premawardhena

    Background: Leg ulceration is a debilitating complication of thalassaemia syndromes, particularly among patients with non-transfusion-dependent thalassaemia (NTDT). Although chronic anaemia is considered a major contributor, clinically relevant haemoglobin (Hb) thresholds associated with ulcer development remain poorly defined. Methods: We conducted a retrospective longitudinal cohort study of patients managed at a specialised Adult and Adolescent Thalassaemia Care Centre established in 2011. Iterative generalised linear mixed-effects modelling (GLMM) with a logit link function was utilised across 84 patients to systematically identify high-risk longitudinal Hb thresholds for the entire cohort and stratified by genotype. A subsequent multi-exposure GLMM framework evaluated independent clinical risk factors, adjusted for sex and genotype. Results: Iterative threshold testing across the entire cohort identified an optimal biological and statistical cutoff at Hb < 5.0 g/dL, associated with a significant risk of ulceration (partially adjusted OR = 2.87, 95% CI: 1.15 - 7.14, P = 0.024). Genotype-stratified analysis revealed that this threshold effect was predominantly driven by the HbEβ-thalassaemia subpopulation, in which the risk escalated sharply between 4.5g/dL (OR = 33.28, P = 0.001) and 5.5g/dL (OR = 2.42, P = 0.023). In the fully adjusted multivariable model, an Hb < 5.0g/dL remained a robust, independent driver of ulceration (aOR = 2.67, 95%CI: 1.08 - 6.62, P = 0.034). Additionally, active follow-up duration (aOR = 1.17 per year, P < 0.001) and cumulative transfusion burden (aOR = 1.43 per unit, P = 0.004) were identified as independent risk factors. Gender and underlying genotype demonstrated no independent association (P > 0.05). Conclusions: A longitudinal hemoglobin level below 5.0g/dL represents a critical threshold for lower-extremity ulceration in thalassaemia, exhibiting a particularly profound risk in HbE/β-thalassaemia. Proactive clinical management targeted at sustaining Hb levels strictly above this threshold, while managing secondary complications reflected by transfusion burden, may optimise microvascular outcomes.

  • Open Access

    Analytical Discordance Between Point-of-Care Troponin Assays and a Central Laboratory High-Sensitivity Assay in a Sri Lankan Hospital Setting: Implications for Implementation

    by Kavindya Fernando, Nilshan Fernando, Dilini Jayasekara, Bktp Dayanath

    Point-of-care testing (POCT) for cardiac troponin is increasingly used to support rapid clinical decision-making, particularly in resource-limited settings. However, while many central laboratories, including those in Sri Lanka, now use high-sensitivity cardiac troponin I (hs-cTnI) assays, commonly available POCT platforms continue to use conventional methodologies with different analytical characteristics and decision thresholds. We evaluated the analytical agreement and clinical concordance of two POCT troponin assays against a central laboratory hs-cTnI assay using paired samples obtained during routine clinical care in a Sri Lankan hospital. Both POCT devices demonstrated strong correlation with the laboratory assay (Pearson r ≈ 0.90). However, Bland–Altman analysis showed substantial positive bias and wide limits of agreement, indicating poor interchangeability at the individual sample level, with proportional bias observed in one device. Clinically relevant discordance was also identified, with 26.9% and 30.4% of samples classified as negative by POCT despite being positive by the reference assay. Regression-based recalibration did not significantly improve concordance. These findings highlight that strong correlation does not ensure diagnostic agreement, emphasizing the need for local validation before integrating POCT troponin assays into established hs-cTnI diagnostic pathways.

  • Open Access

    Application of HEART, GRACE 2.0 and TIMI scores for risk stratification of chest pain: a single-centre external pilot study in a Sri Lankan population

    by C. Welhenge, K. M. Fernando, J. N. Fernando, P. C. Deshapriya, M. L. D. Lekamge, A. Kasturiratne, A. P. De Silva

    HEART score is widely used for risk stratification in patients with chest pain. TIMI and GRACE 2.0 scores are recommended for prognostication in patients w

    • 5 December 2025
      • Vol. 36  (4) , 465-474
    Open Access

    Evaluating the Interference of Residual 'Teepol' Detergent on Serum Electrolytes, Protein, and Cholesterol: An In-Vitro Study.

    by Kavindya Fernando, Dilini Jayasekara, Chiranthi Welhenge, Mihilie Kulasinghe, Piumi Silva, Bktp Dayanath

    In low-resource settings, reusing blood collection tubes cleaned with detergents such as 'Teepol' is common due to economic constraints. However, residual detergent may interfere with biochemical assays. This study evaluated the effect of residual 'Teepol' on serum electrolyte, total protein, and cholesterol, with emphasis on direct ion-selective electrode (ISE) methods. A controlled interference experiment was conducted using pooled human serum spiked with increasing concentrations of 'Teepol' (0%, 0.2%, 0.5%, and 1.0% v/v of original detergent). Serum sodium and potassium were measured using direct ISE (Ortho_Vitros® 4600), while total protein and cholesterol were measured via colorimetric methods (BS 800M). All analytes were tested in a single run to avoid inter-run variability. Statistical significance was assessed via Pearson correlation and comparison against 95% confidence intervals derived from quality control data. Serum sodium and potassium showed a concentration-dependent decline with increasing 'Teepol'. At 1.0%, sodium decreased by ~12% and potassium by ~43% compared to control, with values falling outside the 95% confidence intervals, confirming significant interference. Total protein and cholesterol measurements remained within expected analytical variation. Strong negative correlations were observed for sodium (R=-0.966) and potassium (R=-0.989) with 'Teepol' concentration (p< 0.05). Residual 'Teepol' ≥0.5% v/v significantly interferes with serum sodium and potassium measurements using direct ISE. These findings highlight the importance of strict tube-washing protocols or the use of disposable tubes for critical assays. Inconsistent cleaning practices in low-resource laboratories may allow such interference, posing a risk to result accuracy and clinical decision-making.

  • Open Access

    Evaluation of HEART score, GRACE 2.0 score, and TIMI score for Risk Stratification in Acute Coronary Syndrome: A Single-Centre Pilot Study in a Sri Lankan Population

    by Chiranthi Welhenge, Km Fernando, Jn Fernando, Pc Deshapriya, Mld Lekamge, A Kasturiratne, AP De Silva, Kavindya Fernando, Nilshan Fernando, Dilakshi Lekamge, et al.

    Objectives: HEART score is widely used for risk stratification, in patients with chest pain, to rule out acute coronary syndrome (ACS). Although limited, it has been validated in several countries throughout the world. TIMI and GRACE 2.0 scores are recommended for prognostication in patients with ACS. This study aimed to explore the effectiveness of HEART score, in a Sri Lankan population, for risk stratification, in patients presenting with chest pain and to compare its performance with GRACE 2.0 and TIMI scores. Methods: Data was collected from 74 patients presenting to the emergency department at a tertiary care centre in Sri Lanka. HEART, GRACE 2.0 and TIMI scores were calculated for each patient separately. The predictive accuracy of the HEART score with a diagnosis of ACS and the occurrence of major adverse cardiac events (MACE) at 6 weeks was assessed and compared with TIMI and GRACE 2.0. scores. Results: Area under receiver operating curve (AUC-ROC) for HEART, GRACE 2.0 and TIMI, for a diagnosis of ACS, were 0.889 (95% CI: 0.8171 - 0.9609), 0.805 (95% CI: 0.6758 - 0.9349), 0.812 (95% CI: 0.6961 - 0.9278) respectively. Delong’s test did not indicate a significant pairwise difference in scores. AUC-ROC for occurrence of MACE were 0.905 (95% CI: 0.8437 - 0.9669), 0.721 (95% CI: 0.5934 – 0.8493) and 0.767 (95% CI: 0.6467 – 0.888), for HEART, GRACE 2.0 and TIMI scores respectively, and these differences were statistically significant. Conclusions: HEART score is an effective score which can be used in Sri Lankans, in predicting the probability of ACS, and MACE within 6 weeks, in patients presenting with chest pain. It is comparable to GRACE 2.0 and TIMI scores in diagnostic accuracy while it is superior to GRACE and TIMI scores in predictive accuracy for short term risk of MACE.